Post-earnings recap
Reported
Thu, Aug 9, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Celcuity's earnings report shows a loss per share of $0.18, but the stock rose by 2.69% following the announcement. Investors may be reacting positively to management's focus on clinical programs and long-term strategy despite the lack of revenue data and guidance. The increase in stock price suggests some confidence in the company's future prospects.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.18 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Management remains focused on their clinical development and is optimistic about future opportunities. They acknowledged the challenges but emphasized their commitment to growth.
Management highlighted ongoing efforts to advance their clinical programs.
They expressed confidence in their long-term strategy despite current challenges.